Ricerca retrenches; CRO diversifies client, geographic base

Faced with a recent slowdown in much of the contract research organization (CRO) industry, Ricerca Biosciences LLC has tweaked its focus to solidify its future. The Concord Township, Ohio-based company has shaken up its client base to include more pharmaceutical firms and is growing its Asian operations to take advantage of the increasingly lucrative market.

[Read more of this report]


Ricerca Biosciences offers new comparison analysis service

Contract drug-development organization Ricerca Biosciences LLC is offering a new service that compares drug candidates to a large reference set of pharmacologically active compounds.The new service, called Foresight, helps predict in vivo effects from in vitro drug data and provides insight into additional compound activities, according to a statement from Concord Township, Ohio-based [...]

[Read more of this report]


Ricerca Biosciences agrees to buy drug discovery, development unit from MDS Pharma Services

Contract drug development organization Ricerca Biosciences LLC has agreed to acquire the discovery and preclinical business of MDS Pharma Services for $35 million less working capital and cap-ex reserve.

[Read more of this report]


Are venture capitalists ready to resume biomedical investing?

Biomedical companies with compelling technologies could win millions of dollars in investments this year despite the worst gloom in financial markets since the Great Depression.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics